Tribune News Service
New Delhi, October 23
Two days after India crossed the one billion Covid dose milestone, prime minister Narendra Modi met domestic vaccine makers hailing their enterprise and urged them to gear for potential future pandemics.
The engagement saw the PM discuss ways to take Indian vaccine manufacturing forward and industry leaders lauding “a never before seen government-private collaboration for public good.”
“We discussed how to take the vaccine industry forward and prepare for future pandemics, how to continue enhancing our capacity. All over the world now, countries are going to invest in vaccine production and India needs to be on the forefront of that. We talked of how to do that with the government,” said Adar Poonawalla, CEO, Serum Institute, the makers of Covishield which constitutes 90 pc of the Indian vaccine supplies currently.
The interaction was attended by SII patron Cyrus Poonawalla; Krishna Ella Suchitra Ella of Bharat Biotech International (Covaxin makers); Pankaj Patel and Shervil Patel of Zydus Cadila (developers of the world’s first DNA Covid vaccine ZyCov-D recently cleared by the drug regulator).
Mahima Datla and Narender Mantela of Biological E; Sanjay Singh and Satish Ramanlal Mehta of Gennova Biopharmaceuticals; Satish Reddy and Deepak Sapra of Dr. Reddy's Lab and Rajesh Jain and Harshit Jain of Panacea Biotec also attended along with Health Minister Mansukh Mandaviya.
The PM praised vaccine manufacturers for helping India cross the 100 crore vaccination milestone and imbuing citizens with confidence.
He asked for best practices of the Covid years to be institutionalized.
“This is an opportunity to modify Indian practices in line with global standards. The world is looking up to India in the backdrop of the success of our vaccination drive. Domestic vaccine makers should work together to be ready for future challenges,” the PM said at the meeting at his residence.
Industry leaders hailed PM’s leadership saying one billion dose mark could not have been achieved without his backing.
They hailed applauded regulatory reforms, simplified procedures, timely approvals, and forthcoming and supportive nature of the government throughout Covid innovation years.
The leaders noted that with old practices, there would have been considerable delays and the current pace of vaccine coverage would not have become possible.
“The regulatory reforms the government brought are praiseworthy,” Adar Poonawalla said.
Don't MissView All
WHO has named the variant 'Omicron'
The meeting is being attended by Cabinet Secretary Rajiv Gau...
The raids were conducted on November 16 and 40 premises of t...
A heavy police force and fire tenders have reached the spot
The incident took place at Hotel Clarks Amer where the weddi...